Home

About Us

Publications

PhO in the Media

Our Conferences

Resources

Pharma-Free CME

Teaching Tools

News Archive

Drug Industry

Contact Us

How You Can Help

NEWS FEED

Prescription for Conflict:
Should Industry Fund Continuing Medical Education?

---

Agenda
Friday, June 25, 2010
Georgetown University
Intercultural Center Auditorium
Washington, DC

7:30-8:00am
Registration, Continental breakfast

8:00-8:15am
Opening Remarks

Stephen Ray Mitchell, MD, Dean for Medical Education
Georgetown University Medical Center

Thomas Insel, MD, Director, National Institute of Mental Health, National Institutes of Health

Anthony Scialli, MD, Clinical Professor of Obstetrics and Gynecology, George Washington University School of Medicine

8:15-8:45am
Drug Companies and Medical Knowledge

Joel Lexchin, MD, Professor
York University and University of Toronto

8:45-10:00am
What’s Known About Industry Influence on Continuing Education of Prescribers?

Elissa Ladd, PhD, RN, Assistant Clinical Professor
MGH Institute of Health Professions

Daniel Carlat, MD, Associate Clinical Professor of Psychiatry, Tufts University School of Medicine, Editor, Carlat Psychiatry Report

Adriane Fugh-Berman, MD, Associate Professor
Georgetown University Medical Center

Jeremy Greene, MD, PhD, Assistant Professor, Harvard University

10:00-10:30am
Break

10:30-11:15am
Professionalism

Edmund Pellegrino, MD, Professor Emeritus of Medicine and Medical Ethics, Kennedy Institute of Ethics, Georgetown University

Michael Frisch, JD, Ethics Counsel
Georgetown University Law Center

11:15am-12:00pm
Federal Views

Joshua Sharfstein, MD, Principal Deputy Commissioner
U.S. Food and Drug Administration

Paul Thacker, Senior Investigator
Office of Senator Chuck Grassley

Julie Taitsman, JD, MD, U.S. Department of Health and Human Services Office of Inspector General

12:00-1:15pm
Lunch

1:15-1:45pm
Bioethicists and Pharma

Carl Elliott, MD, PhD, Professor, Center for Bioethics, University of Minnesota School of Medicine

1:45-2:30pm
Views from Former Insiders

Mark E. Helm, MD, MBA, Helm Benefit Design, President

Douglas Melnick, MD, MPH, Physician, Los Angeles, CA

Glenn Demott, MS, Columbus, OH

2:30-2:45pm
Break

2:45-4:00pm
Pros and Cons of Industry-Funded Education

Maureen Doyle-Scharff, MBA, FACME
Senior Director, Team Lead, Medical Education Group, External Medical Communications
Pfizer, Inc

Norman Kahn, MD, Executive Vice-President and CEO
Council of Medical Specialty Societies

David Davis, MD, Senior Director, Continuing Education and Performance Improvement, Association of American Medical Colleges

Mike Saxton, MEd, Consultant

Douglas Melnick, MD, MPH, Physician, Los Angeles, CA

Moderator: Alicia Mundy, Wall Street Journal

4:00-4:45pm
Is Industry-free CME a Sustainable Model?

Robert Wittes, MD, Physician-in-Chief
Memorial Sloan-Kettering Cancer Center

Steve Willis, MD, Professor, East Carolina University, Executive Director, Eastern Area Health Education Center

Hanadi Shamkhani, MD, RPh, Kaiser-Permanente

4:45-5:30pm
Next Steps-Discussion

5:30-7:00pm
Reception


Return to top of page

Return to conference home page

Our Videos



Pharma Insider II
Opposition research
(read transcript)

---

Pharma Insider I
Off-label promotion under the radar
(read transcript)

---

The Art of Medical Writing
Pharma's anonymous writers

---

Drug Reps Talk Shop II
Drug reps continue their chat

---

Drug Reps Talk Shop I Selling drugs to docs

---

Director of PharmedOut Explains the Project

---

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug

---